Stefano Busani

[Stefano Busani @BusaniStefano]

Altmetric – Revisited Hyperoxia Pathophysiology in the Perioperative Setting:… https://t.co/vH7zP2LPRw

[modenaICUgroup @modenaICUgroup]

#COVID19 cytokine blocking agents with steroids improve survival in ICU patients early in the first wave. 1 year of rejections because observational, accepted after RCT confirmed the benefit. Evidence needs time but often patients do not have enough! 🤔

https://t.co/i6nQFHFiy9

[Stefano Busani @BusaniStefano]

Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol https://t.co/4pUHH5PBPu

[Stefano Busani @BusaniStefano]

https://t.co/WIWySKrq1w

[modenaICUgroup @modenaICUgroup]

#COVID19 Forecasting by numbers is better than prediction by subjective opinions. Thanks to @gioguara together with @BusaniStefano @maxdulac @TonelliRoberto @chiccoclini @cossarizza and @MOCOV19 WG

#PLOSONE: https://t.co/B0WusuBYq6

[Stefano Busani @BusaniStefano]

https://t.co/OwfmvrC2k3

[modenaICUgroup @modenaICUgroup]

#COVID19 #immune Another piece of knowledge @cossarizza 👏👏👏 @BusaniStefano @maxdulac @gioguara
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia | EMBO Molecular Medicine https://t.co/VExiUsFNVI

[Therapeutic Advances in Respiratory Disease @TARespirDis]

New article in Therapeutic Advances in Respiratory Disease: Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia https://t.co/lBXCL0qg7Z
#respiratory #pulmonary #OpenAccess Surfactant replacement might help recovery of low-compliance lung

[modenaICUgroup @modenaICUgroup]

#COVID19 #ICU one more option but needs confirmation @BusaniStefano @gioguara @TonelliRoberto @maxdulac
https://t.co/EcvTYc544w

[modenaICUgroup @modenaICUgroup]

#COVID19 patients to handle with super care #MoCo19 @gioguara @BusaniStefano @maxdulac @TonelliRoberto @chiccoclini
https://t.co/k1vbJLdVH5

[modenaICUgroup @modenaICUgroup]

#COVID19 #ICU Ready to go with the #STAUNCH trial🇮🇹
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection
https://t.co/LGZEoZa434

[modenaICUgroup @modenaICUgroup]

#COVID19 consider the unusual presentations @gioguara @BusaniStefano https://t.co/sVaEOyyuL9

[modenaICUgroup @modenaICUgroup]

#Sepsis #Immunity #MDR #ICU an additional piece of the puzzle. @cossarizza @BusaniStefano @maxdulac https://t.co/TtHPrA87KZ